PortalPublikationenEconomic and care considerations of Marfan syndrome

Economic and care considerations of Marfan syndrome

Standard

Economic and care considerations of Marfan syndrome. / Blankart, Carl Rudolf; Milstein, Ricarda; Rybczynski, Meike; Schüler, Helke; von Kodolitsch, Yskert.

in: EXPERT REV PHARM OUT, Jahrgang 16, Nr. 5, 10.2016, S. 591-598.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Harvard

Blankart, CR, Milstein, R, Rybczynski, M, Schüler, H & von Kodolitsch, Y 2016, 'Economic and care considerations of Marfan syndrome', EXPERT REV PHARM OUT, Jg. 16, Nr. 5, S. 591-598. https://doi.org/10.1080/14737167.2016.1240619

APA

Blankart, C. R., Milstein, R., Rybczynski, M., Schüler, H., & von Kodolitsch, Y. (2016). Economic and care considerations of Marfan syndrome. EXPERT REV PHARM OUT, 16(5), 591-598. https://doi.org/10.1080/14737167.2016.1240619

Vancouver

Blankart CR, Milstein R, Rybczynski M, Schüler H, von Kodolitsch Y. Economic and care considerations of Marfan syndrome. EXPERT REV PHARM OUT. 2016 Okt;16(5):591-598. https://doi.org/10.1080/14737167.2016.1240619

Bibtex

@article{279d2e8093a0443aa73d02499f5eb4b7,
title = "Economic and care considerations of Marfan syndrome",
abstract = "INTRODUCTION: Marfan syndrome is a rare multisystem disease of the connective tissue, which affects multiple organ systems. advances in healthcare have doubled the life-expectancy of patients over the past three decades. to date, there is no comprehensive review that consolidates economic considerations and care for marfan patients. Areas covered: Present research suggests that there may be a link between treatment pattern, disease progression and economic costs of Marfan syndrome. It indicates that an early detection of the disease and preventive interventions achieve a dual aim. From a patient perspective, it may reduce the amount of emergency surgery or intervention, and inpatient stays. In addition, it slows disease progression, lowers lifestyle restrictions, reduces psychological stress, and improves health-related quality of life. Expert commentary: Early detection and preventive measures are likely to achieve a dual aim by simultaneously containing costs and reducing the number and length of inpatient stays.",
keywords = "Disease Progression, Health Care Costs, Hospitalization/statistics & numerical data, Humans, Length of Stay, Life Expectancy, Life Style, Marfan Syndrome/economics, Quality of Life, Stress, Psychological/etiology",
author = "Blankart, {Carl Rudolf} and Ricarda Milstein and Meike Rybczynski and Helke Sch{\"u}ler and {von Kodolitsch}, Yskert",
year = "2016",
month = oct,
doi = "10.1080/14737167.2016.1240619",
language = "English",
volume = "16",
pages = "591--598",
journal = "EXPERT REV PHARM OUT",
issn = "1473-7167",
publisher = "EXPERT REVIEWS",
number = "5",

}

RIS

TY - JOUR

T1 - Economic and care considerations of Marfan syndrome

AU - Blankart, Carl Rudolf

AU - Milstein, Ricarda

AU - Rybczynski, Meike

AU - Schüler, Helke

AU - von Kodolitsch, Yskert

PY - 2016/10

Y1 - 2016/10

N2 - INTRODUCTION: Marfan syndrome is a rare multisystem disease of the connective tissue, which affects multiple organ systems. advances in healthcare have doubled the life-expectancy of patients over the past three decades. to date, there is no comprehensive review that consolidates economic considerations and care for marfan patients. Areas covered: Present research suggests that there may be a link between treatment pattern, disease progression and economic costs of Marfan syndrome. It indicates that an early detection of the disease and preventive interventions achieve a dual aim. From a patient perspective, it may reduce the amount of emergency surgery or intervention, and inpatient stays. In addition, it slows disease progression, lowers lifestyle restrictions, reduces psychological stress, and improves health-related quality of life. Expert commentary: Early detection and preventive measures are likely to achieve a dual aim by simultaneously containing costs and reducing the number and length of inpatient stays.

AB - INTRODUCTION: Marfan syndrome is a rare multisystem disease of the connective tissue, which affects multiple organ systems. advances in healthcare have doubled the life-expectancy of patients over the past three decades. to date, there is no comprehensive review that consolidates economic considerations and care for marfan patients. Areas covered: Present research suggests that there may be a link between treatment pattern, disease progression and economic costs of Marfan syndrome. It indicates that an early detection of the disease and preventive interventions achieve a dual aim. From a patient perspective, it may reduce the amount of emergency surgery or intervention, and inpatient stays. In addition, it slows disease progression, lowers lifestyle restrictions, reduces psychological stress, and improves health-related quality of life. Expert commentary: Early detection and preventive measures are likely to achieve a dual aim by simultaneously containing costs and reducing the number and length of inpatient stays.

KW - Disease Progression

KW - Health Care Costs

KW - Hospitalization/statistics & numerical data

KW - Humans

KW - Length of Stay

KW - Life Expectancy

KW - Life Style

KW - Marfan Syndrome/economics

KW - Quality of Life

KW - Stress, Psychological/etiology

U2 - 10.1080/14737167.2016.1240619

DO - 10.1080/14737167.2016.1240619

M3 - SCORING: Review article

C2 - 27662508

VL - 16

SP - 591

EP - 598

JO - EXPERT REV PHARM OUT

JF - EXPERT REV PHARM OUT

SN - 1473-7167

IS - 5

ER -